Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GRECCAR 15: Chemotherapy +/- Pelvic Reirradiation for Locally Recurrent Rectal Cancer
NCT03879109Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Jul 2019
- Primary completion
- Jun 2024
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in rectal cancer (2 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Proportion of curative surgery (R0). Started Jul 2019; status: completed.
02
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT03879109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03879109.